Tower Research Capital (TRC)’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-77,282
Closed -$2.66M 5637
2020
Q3
$2.66M Buy
77,282
+61,204
+381% +$2.11M 0.03% 245
2020
Q2
$269K Buy
+16,078
New +$269K 0.01% 1546
2019
Q4
Sell
-1,825
Closed -$38K 4786
2019
Q3
$38K Buy
+1,825
New +$38K ﹤0.01% 2007
2019
Q2
Sell
-370
Closed -$8K 4626
2019
Q1
$8K Sell
370
-1,470
-80% -$31.8K ﹤0.01% 2841
2018
Q4
$44K Buy
1,840
+708
+63% +$16.9K ﹤0.01% 1373
2018
Q3
$31K Buy
+1,132
New +$31K ﹤0.01% 2060
2018
Q1
Sell
-2,232
Closed -$84K 4195
2017
Q4
$84K Sell
2,232
-3,131
-58% -$118K 0.01% 979
2017
Q3
$133K Buy
+5,363
New +$133K 0.01% 1096
2017
Q1
Sell
-1,235
Closed -$26K 4282
2016
Q4
$26K Buy
+1,235
New +$26K ﹤0.01% 1923
2016
Q3
Sell
-148
Closed -$2K 4837
2016
Q2
$2K Sell
148
-2,712
-95% -$36.6K ﹤0.01% 4028
2016
Q1
$39K Buy
2,860
+2,541
+797% +$34.7K 0.01% 919
2015
Q4
$6K Sell
319
-3,645
-92% -$68.6K ﹤0.01% 2862
2015
Q3
$100K Buy
+3,964
New +$100K 0.01% 568